Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 163

Results For "INST"

3147 News Found

Ministry of Minority Affairs supports development of unani medicine system
Policy | May 26, 2023

Ministry of Minority Affairs supports development of unani medicine system

Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru


Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs
Biotech | May 25, 2023

Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs

The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets


Mandaviya addresses 76th World Health Assembly
News | May 25, 2023

Mandaviya addresses 76th World Health Assembly

The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world


Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
News | May 25, 2023

Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr

The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023


Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
News | May 24, 2023

Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr

The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023


Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
News | May 23, 2023

Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr

The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023


Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr
News | May 22, 2023

Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr

Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023


Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr
News | May 22, 2023

Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr

Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023


GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr
News | May 22, 2023

GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr

The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023


Modi addresses 76th session of the World Health Assembly in Geneva virtually
News | May 22, 2023

Modi addresses 76th session of the World Health Assembly in Geneva virtually

India’s efforts are aimed at boosting health at the last mile